Totally believe this! My patients LOVE the idea of "natural" supplements

Infographic summarizing a JAMA study on home-delivered groceries and blood pressure in Black adults. Key findings: DASH grocery delivery resulted in -5.7 mm Hg change, self-directed shopping -2.3 mm Hg. The between-group difference was -3.4 mm Hg.

RCT: Home-delivered, low-sodium Dietary Approaches to Stop Hypertension (DASH) groceries and dietitian support temporarily improved blood pressure and LDL cholesterol in Black adults with high BP versus monetary support.

#AHA25 @ahascience.bsky.social

ja.ma/4oZ5JVI

Congrats to the incoming AJKD editorial interns! Just finished my last editorial call as a 2024-2025 intern and it was such a fantastic experience. Highly recommend to anyone interested in a research career. Very grateful to everyone on the @ajkd.bsky.social editorial board for teaching us so much!

Figure 3 Annual carbon impact, in kg CO2e, for each dialysis modality

Answer:
- in centre HD, of course. But driven by: patient transportation to the unit 3 X week!

#NephSky

Source: @kireports.bsky.social www.ajkd.org/article/S027...

How Machine Learning Could Help Target Nudges This Medical News article is an interview with Stanford University economist Susan Athey, PhD, about the clinical practice implications of her recent research on machine learning and causal vs predict...

"How do you figure that out if you’ve just run a large-scale randomized experiment?"

In this Medical News article, economist Susan Athey discusses the effectiveness of machine learning in targeting interventions.

#MedSky

This #ASNKidneyNews policy update highlights two ongoing reforms in policy and quality programs:

1. Reform to the Centers for Medicare and Medicaid End-Stage Renal Disease Prospective Payment System.

2. Transparency and Medicare Advantage, focusing on quality. kidney.pub/KN1706-07

Limited Survival Benefit Seen in Some Patients With Kidney Transplant | Docwire News Survival benefits of deceased-donor kidney transplantation decrease when older, high-risk patients receive lower-quality organs.

Survival advantages of deceased-donor kidney transplantation don't apply to all patients and donor organs, findings presented at #ERA25 suggested. #nephrology #nephsky #kidneytransplant #transplantation www.docwirenews.com/post/limited...

How do patients select dialysis facilities? Proximity? Quality? Preserving care continuity with their nephrologist?

Our latest in @JAMAHealthForum
suggests patients value proximity and care continuity.

Quality gets sacrificed

🧵(link at end) 1/

While health regulations are usually well intentioned they often are poorly implemented

Dialysis is a prime example of regulation perpetuating a consolidated industry with no market competition, poor outcomes &price gouging

New in HealthAffairs Forefront

🧵1/ (link at end)

x.com/Health_Affai...

Note that pts with NO part D plans had >30pp MORE calcimimetic rx fills after the policy ‼️
(A limitation is that pts w/o Part D plans *could* have been receiving calcimimetics thru drug samples or an employer-sponsored plan, which wouldn't have showed up in our data.)

Money shot below ⬇️
Compare to pts with FULL rx subsidies (who pay $0), pts with pts with Part D but NO subsidies had 10pp more rx fills, and pts with PARTIAL subsidies had 2pp more rx fills post-TDAPA.
i.e., the more you paid pre-TDAPA, the more meds you filled post-policy

I hear that the phos binder roll-out has been painful thus far - but our findings suggest that covering meds under TDAPA *might* actually increase prescription fills, especially for patients subject to high OOP costs under Part D 🤞🏻

Latest publication! 🚨
TL;DR:
1) MANY patients on dialysis pay high OOP costs for drugs 💸
-- nearly 20% have NO PART D plan
-- 25% have NO rx subsidies
2) Covering calcimimetics in Part B via TDAPA instead of Part D INCREASED rx fills 📈
Check out @eugelin06.bsky.social's 🧵 & our paper ⬇️

Use of No-Cost Preventive Services Jeopardized by Kennedy v Braidwood This cross-sectional study analyzes the use of 10 no-cost preventive services by individuals with employer-sponsored health insurance, which may be threatened by the upcoming Kennedy v Braidwood Supre...

On Monday the Supreme Court hears a case that could strike down the ACA mandate that insurers cover preventive services at no cost to patients.

We found that ~40 million people with private insurance use these free services, including half of enrolled women.

JAMA Health Forum:
ja.ma/3GcUZC6

🩺📊

What role do you think Medicaid/insurance status plays here? I could imagine patients with Medicaid alone prior to dialysis initiation have poorer access to high-quality nephrologists (and less pre-dialysis nephrology care overall).

Kidney Transplant Wait Times Under Waiting List Expansion Scenarios This decision analytic model evaluates time to kidney transplant under different scenarios of expanding waiting lists, deceased-donor transplants, and living-donor transplants.

Only 12% of patients receiving dialysis are currently on the transplant wait list. We estimate that over 11,000 additional organs would be needed to increase that number to 18%. ja.ma/4c0MNkj + check out the editorial too!

Thx to my amazing mentors and @kidneyfund.bsky.social for their support.

Congrats to both of you!!! 👏🏻👏🏻👏🏻

We are excited to announce the 2025 AKF Clinical Scientist in Nephrology (CSN) fellows! Join us in congratulating Dr. Momen Abbasi, a nephrology fellow at the University of Illinois Chicago & Dr. Api Chewcharat, a nephrology fellow at @mgbresearch.bsky.social: www.kidneyfund.org/article/amer...

#NephMadness 2025: The PodCrawl Submit your picks! |  @NephMadness |@nephmadness.bsky.social | NephMadness 2025 Over the next couple of weeks, NephMadness 2025 will be popping up on some great podcasts.  Keep your eyes and ears o…

#NephMadness 2025: The PodCrawl

buff.ly/p3xR3cg

Podcasts:
- @thecurbsiders.bsky.social
- Life as a Nephrology Professional @nkf-professionals.bsky.social
- GN in Ten
- @rheummadness.bsky.social
- @freelyfiltered.bsky.social
- Poison Lab
- Nephron Segment
- Kidney Chronicles

Excellent news!!! 🙌🏻

Visual abstract for "Estimating the Benefit of Transplant Over Dialysis in Candidates Over 55 Years."

Life Years from Transplant (LYFT) is a measure of the predicted difference between the expected lifespan with and without a kidney transplant. This study found that less homogenous metrics with meaningful disaggregation are needed to inform institutional evaluation and policy change. bit.ly/KID0710